Canalblog
Suivre ce blog Administration + Créer mon blog
Publicité

Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)

22 juin 2015

NEWS: NEW PUBLICATIONS UPTO JUNE 21ST 2015

NEWS: NEW PUBLICATIONS UPTO JUNE 21ST 2015
Eye - Figure 3 for article: In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: a pilot study Eye is the official journal of the Royal College of...
Publicité
Publicité
22 juin 2015

Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model.

Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model.
Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model. Lien: P0588 [Article in Chinese] Zhang Y , Li J , Chi Y , Li M , Pan X , Zhang Q , He X , Liu Y 1. Author information Abstract...
19 juin 2015

Targeting Ocular Disorders Conference

Targeting Ocular Disorders Conference
Targeting Ocular Disorders Conference Targeting Ocular Disorders - Overview Ophthalmological pharmacology has historically lacked systematic understanding of disease mechanisms, especially of those for the back of the eye. This is now changing with the...
15 juin 2015

PUBLICATIONS UPTO JUNE 13 TH 2015

PUBLICATIONS UPTO JUNE 13 TH 2015
PUBLICATIONS UPTO JUNE 13TH 2015 treatment of meibomian gland dysfunction - PubMed - NCBI PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text...
10 juin 2015

Optometrist seeing more patients with dry eyes

Optometrist seeing more patients with dry eyes
Optometrist seeing more patients with dry eyes Optometrist seeing more patients with dry eyes SOMERSWORTH - Dr. Susan Haskell, a doctor of optometry at Eyesight Ophthalmic Services, is seeing an increasing number of patients with dry eye syndrome."I see...
Publicité
Publicité
8 juin 2015

NEWS UPTO JUNE 7TH 2015

NEWS UPTO JUNE 7TH 2015
NEWS UPTO JUNE 7TH 2015 1. BMC Ophthalmol. 2015 Jun 6;15(1):58. Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye. Ueda K 1, Matsumiya W 2, Otsuka K 3, Maeda Y 4, Nagai T 5, Nakamura M 6. Author information:...
8 juin 2015

Rho kinase-dependent actin turnover and actomyosin disassembly are necessary for mouse spinal neural tube closure.

Rho kinase-dependent actin turnover and actomyosin disassembly are necessary for mouse spinal neural tube closure.
Rho kinase-dependent actin turnover and actomyosin disassembly are necessary for mouse spinal neural tube closure. Escuin S 1, Vernay B 1, Savery D 1, Gurniak CB 2, Witke W 2, Greene ND 1, Copp AJ 3. Author information Abstract The cytoskeleton is widely...
7 juin 2015

Evaluation of a Smart-Phone Based Ocular Imaging System for the Assessment of Conjunctival Hyperemia

Evaluation of a Smart-Phone Based Ocular Imaging System for the Assessment of Conjunctival Hyperemia
Evaluation of a Smart-Phone Based Ocular Imaging System for the Assessment of Conjunctival Hyperemia Dry Eye | Ora RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye... http://www.oraclinical.com Conjunctival...
5 juin 2015

A Stepwise Approach To Acute Dry Eye

A Stepwise Approach To Acute Dry Eye
A Stepwise Approach To Acute Dry Eye A Stepwise Approach To Acute Dry Eye Dry-eye disease is well-recognized as a complex, chronic disease that needs chronic therapy. Superimposed on the intricate landscape of oxidative processes, immunological priming,...
4 juin 2015

More patients experience phantom eye symptoms every day, say University of Liverpool researchers

More patients experience phantom eye symptoms every day, say University of Liverpool researchers
More patients experience phantom eye symptoms every day, say University of Liverpool researchers More patients experience phantom eye symptoms every day, say University of Liverpool researchers Researchers from the University of Liverpool have found that...
2 juin 2015

TARGETING OCULAR DISORDERS

TARGETING OCULAR DISORDERS
Targeting Ocular Disorders - Overview Ophthalmological pharmacology has historically lacked systematic understanding of disease mechanisms, especially of those for the back of the eye. This is now changing with the discovery of novel targets and pathways...
1 juin 2015

NEW PUBLICATIONS UPTO MAY 31TH EPUB

NEW PUBLICATIONS UPTO MAY 31TH EPUB
NEW PUBLICATIONS UPTPO MAY 31TH IOVS | Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye http://iovs.arvojournals.org Invest Ophthalmol Vis Sci. 2015 May 1;56(5):3149-58. doi: 10.1167/iovs.14-16153....
29 mai 2015

May 27, 2015 Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2015

May 27, 2015 Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2015
May 27, 2015 Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2015 Press release distribution, EDGAR filing, XBRL, regulatory filings | Business Wire The global leader in press release distribution and regulatory disclosure. Public relations...
28 mai 2015

L'Industrie, frein ou moteur à l'innovation ?

L'Industrie, frein ou moteur à l'innovation ?
L'Industrie, frein ou moteur à l'innovation ? Lien: 0ltwy
26 mai 2015

BENEFIT FROM THE COMPREHENSIVE OFFERING OF DRUG DISCOVERY PRODUCTS AND SERVICES

 BENEFIT FROM THE COMPREHENSIVE OFFERING OF DRUG DISCOVERY PRODUCTS AND SERVICES
Eurofins France Le groupe français de biotechnologies Eurofins Scientific, fondé à Nantes en 1987, figure parmi les premiers prestataires mondiaux sur le marché de la bioanalyse. http://www.eurofins.fr BENEFIT FROM THE COMPREHENSIVE OFFERING OF DRUG DISCOVERY...
26 mai 2015

News through publications up to May 25th 2015

News through publications up to May 25th 2015
JBP485 promotes tear and mucin secretion in ocular surface epithelia Journal name: Scientific Reports Volume: 5, Article number: 10248 DOI: doi:10.1038/srep10248 Dry eye syndrome (DES) is one of the most frequently encountered ocular diseases. Epidemiological...
22 mai 2015

APinnov 2015 12ème Rencontres de Transfert de Technologie de l’Assistance Publique – Hôpitaux de Paris

Bonjour, J’ai le plaisir de vous inviter à la 12ème édition d’APinnov, Les inscriptions en ligne sont ouvertes. Bien à vous, Dr Florence GHRENASSIA Pharm. D., MBA Office du Transfert de Technologie & des Partenariats Industriels (DRCD –DOMU) Assistance...
21 mai 2015

Researchers develop nanoparticle eye drops to combat dry eye syndrome

Researchers develop nanoparticle eye drops to combat dry eye syndrome
Researchers develop nanoparticle eye drops to combat dry eye syndrome NANOTECHNOLOGY: A NEW APPROACH FOR OCULAR DRUG DELIVERY SYSTEM: 3714 Published on October 9, 2014 at 10:31 AM For the millions of sufferers of dry eye syndrome, their only recourse...
19 mai 2015

NEW TOOL TO INCREASE USEFULNESS OF CLINICAL TRIALS

NEW TOOL TO INCREASE USEFULNESS OF CLINICAL TRIALS
NEW TOOL TO INCREASE USEFULNESS OF CLINICAL TRIALS NEW TOOL TO INCREASE USEFULNESS OF CLINICAL TRIALS A huge number of clinical trials are poorly designed and as such the results they produce can be irrelevant to real end users, dddmag.com reports. Now...
18 mai 2015

PUBLICATIONS UPTO MAY 17th 2015

PUBLICATIONS UPTO MAY 17th 2015
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% RESTASIS - cyclosporine emulsion Allergan, Inc. ---------- RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% Sterile, Preservative-Free RESTASIS ® (cyclosporine ophthalmic emulsion) 0.05% contains a...
Publicité
Publicité
<< < 1 2 3 4 5 6 7 8 > >>
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
Newsletter
Visiteurs
Depuis la création 33 346
Publicité